[HTML][HTML] Cancer immunotherapy: Pros, cons and beyond
S Tan, D Li, X Zhu - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Cancer immunotherapy is an innovative treatment for tumors today. In various experiments
and clinical studies, it has been found that immunotherapy does have incomparable …
and clinical studies, it has been found that immunotherapy does have incomparable …
Targets of immune escape mechanisms in cancer: basis for development and evolution of cancer immune checkpoint inhibitors
Simple Summary The tumor immune escape mechanisms are key factors in cancer
progression and metastasis. They are an undeniable hurdle for successful cancer treatment …
progression and metastasis. They are an undeniable hurdle for successful cancer treatment …
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
Immune checkpoint blockade (ICB) therapy provides remarkable clinical gains and has
been very successful in treatment of melanoma. However, only a subset of patients with …
been very successful in treatment of melanoma. However, only a subset of patients with …
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Immune checkpoint inhibitors targeting the programmed cell death 1 receptor (PD-1)
improve survival in a subset of patients with clear cell renal cell carcinoma (ccRCC). To …
improve survival in a subset of patients with clear cell renal cell carcinoma (ccRCC). To …
Immunology and immunotherapy of head and neck cancer
RL Ferris - Journal of clinical oncology, 2015 - ascopubs.org
The immune system plays a key role in the development, establishment, and progression of
head and neck squamous cell carcinoma (HNSCC). A greater understanding of the …
head and neck squamous cell carcinoma (HNSCC). A greater understanding of the …
Development of PD-1/PD-L1 pathway in tumor immune microenvironment and treatment for non-small cell lung cancer
J He, Y Hu, M Hu, B Li - Scientific reports, 2015 - nature.com
Lung cancer is currently the leading cause of cancer-related death in worldwide, non-small
cell lung cancer (NSCLC) accounts for about 85% of all lung cancers. Surgery, platinum …
cell lung cancer (NSCLC) accounts for about 85% of all lung cancers. Surgery, platinum …
[HTML][HTML] Targeted therapies in breast cancer: New challenges to fight against resistance
V Masoud, G Pagès - World journal of clinical oncology, 2017 - ncbi.nlm.nih.gov
Breast cancer is the most common type of cancer found in women and today represents a
significant challenge to public health. With the latest breakthroughs in molecular biology and …
significant challenge to public health. With the latest breakthroughs in molecular biology and …
Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
Immunotherapy has prompted a paradigm shift in advanced non-small cell lung cancer
(NSCLC) treatment, by demonstrating superior efficacy to chemotherapy alone both in …
(NSCLC) treatment, by demonstrating superior efficacy to chemotherapy alone both in …
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer
BACKGROUND. Understanding the integrated immunogenomic landscape of advanced
prostate cancer (APC) could impact stratified treatment selection. METHODS. Defective …
prostate cancer (APC) could impact stratified treatment selection. METHODS. Defective …
Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
Immunotherapy sheds new light to cancer treatment and is satisfied by cancer patients.
However, immunotoxicity, single‐source antibodies, and single‐targeting stratege are …
However, immunotoxicity, single‐source antibodies, and single‐targeting stratege are …